These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

217 related articles for article (PubMed ID: 2106816)

  • 1. A 62-dose, 6-month therapy for pulmonary and extrapulmonary tuberculosis. A twice-weekly, directly observed, and cost-effective regimen.
    Cohn DL; Catlin BJ; Peterson KL; Judson FN; Sbarbaro JA
    Ann Intern Med; 1990 Mar; 112(6):407-15. PubMed ID: 2106816
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Treatment of childhood tuberculosis with a six month directly observed regimen of only two weeks of daily therapy.
    Al-Dossary FS; Ong LT; Correa AG; Starke JR
    Pediatr Infect Dis J; 2002 Feb; 21(2):91-7. PubMed ID: 11840073
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Treatment of lymph node tuberculosis--a randomized clinical trial of two 6-month regimens.
    Jawahar MS; Rajaram K; Sivasubramanian S; Paramasivan CN; Chandrasekar K; Kamaludeen MN; Thirithuvathas AJ; Ananthalakshmi V; Prabhakar R
    Trop Med Int Health; 2005 Nov; 10(11):1090-8. PubMed ID: 16262733
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A controlled trial of a 4-weekly supplement of rifampicin, pyrazinamide and streptomycin in the continuation phase of a 7-month daily chemotherapy regimen for pulmonary tuberculosis. Tanzania/British Medical Research Council Collaborative Investigation.
    S Afr Med J; 1996 Aug; 86(8):960-5. PubMed ID: 8823423
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Controlled trial of 6-month and 8-month regimens in the treatment of pulmonary tuberculosis. First report.
    Am Rev Respir Dis; 1978 Aug; 118(2):219-28. PubMed ID: 100029
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Present status of chemotherapy for tuberculosis.
    Grosset JH
    Rev Infect Dis; 1989; 11 Suppl 2():S347-52. PubMed ID: 2652251
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Effectiveness and problems of PZA-containing 6-month regimen for the treatment of new pulmonary tuberculosis patients].
    Wada M
    Kekkaku; 2001 Jan; 76(1):33-43. PubMed ID: 11211781
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Acquired rifamycin monoresistance in patients with HIV-related tuberculosis treated with once-weekly rifapentine and isoniazid. Tuberculosis Trials Consortium.
    Vernon A; Burman W; Benator D; Khan A; Bozeman L
    Lancet; 1999 May; 353(9167):1843-7. PubMed ID: 10359410
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pilot study of twice-weekly therapy for pulmonary tuberculosis in Taiwan.
    Lin CB; Tang M; Hsu AH; Miu WC; Lee YS; Lee JJ
    J Formos Med Assoc; 2011 Jul; 110(7):438-45. PubMed ID: 21742247
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A controlled clinical trial of oral short-course regimens in the treatment of sputum-positive pulmonary tuberculosis. Tuberculosis Research Centre.
    Int J Tuberc Lung Dis; 1997 Dec; 1(6):509-17. PubMed ID: 9487448
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Short-course tuberculosis chemotherapy studies conducted in Poland during the past decade.
    Snider DE; Zierski M; Graczyk J; Bek E; Farer LS
    Eur J Respir Dis; 1986 Jan; 68(1):12-8. PubMed ID: 3512281
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Assessment of a daily combined preparation of isoniazid, rifampin, and pyrazinamide in a controlled trial of three 6-month regimens for smear-positive pulmonary tuberculosis. Singapore Tuberculosis Service/British Medical Research Council.
    Am Rev Respir Dis; 1991 Apr; 143(4 Pt 1):707-12. PubMed ID: 1901200
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Controlled trial of 2, 4, and 6 months of pyrazinamide in 6-month, three-times-weekly regimens for smear-positive pulmonary tuberculosis, including an assessment of a combined preparation of isoniazid, rifampin, and pyrazinamide. Results at 30 months. Hong Kong Chest Service/British Medical Research Council.
    Am Rev Respir Dis; 1991 Apr; 143(4 Pt 1):700-6. PubMed ID: 1901199
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A controlled clinical trial of 3- and 5-month regimens in the treatment of sputum-positive pulmonary tuberculosis in South India. Tuberculosis Research Centre, Madras, and National Tuberculosis Institute, Bangalore.
    Am Rev Respir Dis; 1986 Jul; 134(1):27-33. PubMed ID: 3524334
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Five year results of a 3-month and two 5-month regimens for the treatment of sputum-positive pulmonary tuberculosis in south India.
    Balasubramanian R; Sivasubramanian S; Vijayan VK; Ramachandran R; Jawahar MS; Paramasivan CN; Selvakumar N; Somasundaram PR
    Tubercle; 1990 Dec; 71(4):253-8. PubMed ID: 2125153
    [TBL] [Abstract][Full Text] [Related]  

  • 16. USPHS Tuberculosis Short-Course Chemotherapy Trial 21: effectiveness, toxicity, and acceptability. The report of final results.
    Combs DL; O'Brien RJ; Geiter LJ
    Ann Intern Med; 1990 Mar; 112(6):397-406. PubMed ID: 2155569
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Short-course chemotherapy for extrapulmonary tuberculosis. Nine years' experience.
    Dutt AK; Moers D; Stead WW
    Ann Intern Med; 1986 Jan; 104(1):7-12. PubMed ID: 3940507
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical trial of three 6-month regimens of chemotherapy given intermittently in the continuation phase in the treatment of pulmonary tuberculosis. Singapore Tuberculosis Service/British Medical Research Council.
    Am Rev Respir Dis; 1985 Aug; 132(2):374-8. PubMed ID: 2862820
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Supervised six-months treatment of newly diagnosed pulmonary tuberculosis using isoniazid, rifampin, and pyrazinamide with and without streptomycin.
    Snider DE; Graczyk J; Bek E; Rogowski J
    Am Rev Respir Dis; 1984 Dec; 130(6):1091-4. PubMed ID: 6508006
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Analysis of course and treatment results after treatment of pulmonary tuberculosis with early introduction of interrupted observation--preliminary report].
    Sedlaczek AM; Serwatowski P; Spiewak W
    Pneumonol Alergol Pol; 1995; 63(5-6):293-7. PubMed ID: 7581060
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.